Market drivers: The key driver for the Middle East and Asia Pacific Cell and Gene Therapy Market is growing prevalence of cancer. As per Global Burden of Disease (GBD) estimates, cancer is one of the leading causes of death in Asia Pacific, claiming over 2.2 million lives annually. The prevalence of cancer is significantly high in countries like China, India and Japan. As traditional treatment...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian